Literature DB >> 32504856

TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases.

Susan Erickson1, Amy Gallant Sullivan2, Stefano Barabino3, Enesa Begovic4, Jose M Benitez-Del-Castillo5, Stefano Bonini6, José Salgado Borges7, Vladimir Brzheskiy8, Nina Bulat9, Alma Cerim4, Jennifer P Craig10, Valeriu Cușnir9, Valeriu Cușnir9, Vitalie Cușnir9, Serge Doan11, Erol Dülger12, Sarah Farrant13, Gerd Geerling14, David Goldblum15, Sergey Golubev16, José A P Gomes17, José Manuel González-Méijome18, Christina N Grupcheva19, Ömür Uçakhan Gündüz20, Jutta Horwath-Winter21, Fredrik Källmark22, Nino Karanadze23, Huda Hajjir Karcic4, Suvad Karcic4, Georgios Kontadakis24, Elisabeth M Messmer25, Malgorzata Mrugacz26, Conor Murphy27, Olivia E O'Leary15, Vitalie Procopciuc4, Heiko Pult28, Peter Raus29, Afsun Şahin30, Niko Setälä31, Adriana Stanila32, Dan Mircea Stanila32, Tor Paaske Utheim33, Jelle Vehof34, Piera Versura35, Edoardo Villani36, Mark D P Willcox37, James S Wolffsohn38, Zbigniew Zagórski39, Gunnar Már Zoega40, David A Sullivan41.   

Abstract

The mission of the Tear Film & Ocular Surface Society (TFOS) is to advance the research, literacy, and educational aspects of the scientific field of the tear film and ocular surface. Fundamental to fulfilling this mission is the TFOS Global Ambassador program. TFOS Ambassadors are dynamic and proactive experts, who help promote TFOS initiatives, such as presenting the conclusions and recommendations of the recent TFOS DEWS II™, throughout the world. They also identify unmet needs, and propose future clinical and scientific solutions, for management of ocular surface diseases in their countries. This meeting report addresses such needs and solutions for 25 European countries, as detailed in the TFOS European Ambassador meeting in Rome, Italy, in September 2019.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2020        PMID: 32504856     DOI: 10.1016/j.jtos.2020.05.006

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  1 in total

1.  Reducing the burden of ocular surface disease with serum eye drops.

Authors:  Parwez Hossain
Journal:  Eye (Lond)       Date:  2021-07-01       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.